AU3960800A - Novel method for producing doxazosin mesylate in a crystalline modification designated as form - Google Patents

Novel method for producing doxazosin mesylate in a crystalline modification designated as form

Info

Publication number
AU3960800A
AU3960800A AU39608/00A AU3960800A AU3960800A AU 3960800 A AU3960800 A AU 3960800A AU 39608/00 A AU39608/00 A AU 39608/00A AU 3960800 A AU3960800 A AU 3960800A AU 3960800 A AU3960800 A AU 3960800A
Authority
AU
Australia
Prior art keywords
novel method
crystalline modification
doxazosin mesylate
modification designated
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39608/00A
Inventor
Peter Klein
Marco Thyes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Publication of AU3960800A publication Critical patent/AU3960800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU39608/00A 1999-03-18 2000-03-06 Novel method for producing doxazosin mesylate in a crystalline modification designated as form Abandoned AU3960800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19912063A DE19912063A1 (en) 1999-03-18 1999-03-18 New process for the preparation of doxazosin mesylate in a crystal modification called Form A.
DE19912063 1999-03-18
PCT/EP2000/001939 WO2000056731A1 (en) 1999-03-18 2000-03-06 Novel method for producing doxazosin mesylate in a crystalline modification designated as form a

Publications (1)

Publication Number Publication Date
AU3960800A true AU3960800A (en) 2000-10-09

Family

ID=7901411

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39608/00A Abandoned AU3960800A (en) 1999-03-18 2000-03-06 Novel method for producing doxazosin mesylate in a crystalline modification designated as form

Country Status (13)

Country Link
EP (1) EP1165548A1 (en)
JP (1) JP2002540109A (en)
KR (1) KR20010113753A (en)
CN (1) CN1352643A (en)
AU (1) AU3960800A (en)
CA (1) CA2367903A1 (en)
CZ (1) CZ20013347A3 (en)
DE (1) DE19912063A1 (en)
HU (1) HUP0200663A2 (en)
IL (1) IL144944A0 (en)
PL (1) PL350088A1 (en)
TR (1) TR200102730T2 (en)
WO (1) WO2000056731A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19912573A1 (en) * 1999-03-19 2000-09-21 Knoll Ag Medicament containing doxazosin mesylate of crystal modification D
CA2706372A1 (en) * 2007-12-24 2009-07-02 Cipla Limited Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof
CN109988158A (en) * 2018-01-03 2019-07-09 合肥立方制药股份有限公司 X crystal form, doxazosin mesylate containing X crystal form and its preparation method and application
CN111303130B (en) * 2018-12-11 2021-09-14 合肥立方制药股份有限公司 Doxazosin mesylate crystal form, and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1287588B1 (en) * 1996-12-13 1998-08-06 Alfa Chem Ital CRYSTALLINE FORM OF MESILATE DOXAZOSIN AND PROCESS FOR ITS PRODUCTION
EP0849266B8 (en) * 1996-12-20 2007-10-03 Heumann PCS GmbH Novel polymorphic form of doxazosin mesylate (form III)
DE19800214A1 (en) * 1998-01-06 1999-07-15 Knoll Ag Process for the preparation of doxazosin mcsylate in a crystal modification referred to as Form A and an intermediate therefor

Also Published As

Publication number Publication date
TR200102730T2 (en) 2002-06-21
JP2002540109A (en) 2002-11-26
PL350088A1 (en) 2002-11-04
KR20010113753A (en) 2001-12-28
EP1165548A1 (en) 2002-01-02
WO2000056731A1 (en) 2000-09-28
CN1352643A (en) 2002-06-05
DE19912063A1 (en) 2000-09-21
CA2367903A1 (en) 2000-09-28
HUP0200663A2 (en) 2002-08-28
CZ20013347A3 (en) 2002-01-16
IL144944A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
AU3073400A (en) Method for producing chlorine
AU2003215656A1 (en) Method for producing hollow fibres
AU2002237139A1 (en) Method for producing a rolled edge
AU2002213972A1 (en) Method for producing polyisobutenylphenoles
AU3960800A (en) Novel method for producing doxazosin mesylate in a crystalline modification designated as form
AU2645900A (en) Method for producing a vwf preparation
AU3734301A (en) Method for producing 2-chloro-benzimidazole derivatives
AU7965301A (en) Method for producing polyisobutenes
AU2002212224A1 (en) Method for producing delta1-pyrrolines
AU2002233243A1 (en) Method for producing isocyanates
AU5214300A (en) Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones
AU2001242735A1 (en) Process for producing camptothecin
AU2002218293A1 (en) Method for producing composite elements
AU1283001A (en) Method for producing alkylhalogenosilanes
AU3973800A (en) Method for preparing a sorting scheme
AU1141501A (en) Method for producing hydroxymethylpyridines
AU6691600A (en) Method for producing 4-cyano-2-aminomethylthiazol
AU2001262147A1 (en) Method for producing 4-bromo- and 4-chloro-2-nitro-1-trifluoromethoxybenzene
AU5135600A (en) Process for producing piperidine
AU4480201A (en) Azetidinone derivatives, a process for their preparation and a method for producing 1-beta-alkyl azetidinone using the same
AU2001281953A1 (en) Method for producing ep(d)m
AU1144901A (en) Method for producing organophosphites
AU3280400A (en) Method for producing artificial stone
AU2001263765A1 (en) Method for producing a nonwoven
AU5567500A (en) Process for producing a hairdye composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase